Why Compare Mounjaro and Wegovy Pricing Matters
Compare Mounjaro and Wegovy: Understanding the UK Price Landscape
When you compare Mounjaro and Wegovy pricing in the UK, you're looking at two distinct treatment pathways with different cost structures. Wegovy (semaglutide) pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. These prices include your clinical assessment, prescriber review, and next-day delivery - no hidden extras. Mounjaro (tirzepatide) follows a different pricing model due to its dual GIP and GLP-1 receptor agonist mechanism, which typically commands premium pricing across UK providers.
The key advantage of comparing Mounjaro and Wegovy through EverydayMeds is our transparent pricing structure with discount codes applied at checkout. New customers use code FIRST40, whilst returning customers benefit from code DOSE25 to access our competitive rates. Unlike some providers who advertise low headline prices but add consultation fees, delivery charges, or subscription requirements, our listed prices represent the total cost you'll pay. This transparency helps you budget effectively for your weight management journey, whether you choose the established Wegovy pathway or opt for the newer Mounjaro treatment option.
Wegovy vs Mounjaro Pricing: Bundle Options and Value Comparison
When you compare Mounjaro and Wegovy bundle pricing, Wegovy offers structured progression packages that can provide better value for committed patients. Our Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks of treatment, whilst the Progress Duo (0.5mg & 1mg) is £189.99 for weeks 5-12. For those seeking extended supply security, our Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) at £269.99 allows a slower initial escalation, which some patients prefer for tolerability reasons. The Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, ensuring consistent treatment without monthly reordering.
Mounjaro pricing typically doesn't offer the same bundle flexibility, as most UK providers sell individual pens without progression packages. This makes Wegovy bundles particularly attractive for patients who want to secure their supply chain and avoid monthly purchasing decisions. Remember that both treatments are prescription-only medicines requiring ongoing clinical oversight, so the convenience of bundled supply can reduce administrative burden whilst maintaining clinical safety. Your prescriber can help determine whether a bundle approach suits your individual treatment plan and financial preferences.
Compare Mounjaro and Wegovy Clinical Evidence
When comparing Mounjaro and Wegovy clinical outcomes, both treatments have demonstrated significant efficacy in randomised controlled trials, though direct head-to-head comparisons are limited. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 extension showed sustained clinically studied weight loss at 2 years, demonstrating long-term efficacy when treatment continues.
Mounjaro's SURMOUNT trials showed patients may achieve higher average weight loss percentages, though these trials had different designs, populations, and endpoints, making direct comparison inappropriate. Both treatments work through appetite regulation mechanisms - Wegovy targets GLP-1 receptors exclusively, whilst Mounjaro activates both GIP and GLP-1 receptors as a dual agonist. Clinical evidence suggests both may help reduce food cravings and promote satiety, supporting adherence to reduced-calorie diets when combined with increased physical activity.
How Wegovy Works When You Compare Mounjaro and Wegovy Mechanisms
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone your body produces after eating. When you inject Wegovy once weekly using the FlexTouch pen, it binds to GLP-1 receptors in your brain's appetite control centres, potentially reducing hunger signals and increasing feelings of satiety after smaller meals. This mechanism may help you naturally consume fewer calories without the constant battle against cravings that many people experience during traditional dieting. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged fullness between meals. Unlike Mounjaro's dual-action approach, Wegovy's single-target mechanism has been extensively studied since its development, with over a decade of clinical experience across various populations and BMI ranges.
Compare Mounjaro and Wegovy Ordering Process
Ordering either Mounjaro or Wegovy through EverydayMeds follows the same streamlined process, taking just 3 minutes to complete your online clinical assessment. You'll answer questions about your weight management history, current medications, and health conditions to ensure either treatment is appropriate for your circumstances. Our prescribers typically review applications within 3 working days (express 24-hour service available), and once approved, your medication ships via next-day cold-chain delivery to maintain the required 2-8°C temperature throughout transit. This process applies whether you're comparing Mounjaro and Wegovy options or have already decided on your preferred treatment. Both medications require the same level of clinical oversight as prescription-only medicines, ensuring your safety remains the top priority regardless of which option you choose.
Storage Differences When You Compare Mounjaro and Wegovy
A practical advantage emerges when you compare Mounjaro and Wegovy storage requirements - Wegovy offers superior travel flexibility with 6 weeks of room temperature stability below 30°C, compared to Mounjaro's 21-day limit. Both medications must be stored in the fridge at 2-8°C before first use, but once removed for travel or convenience, Wegovy's extended room temperature window provides greater lifestyle flexibility for frequent travellers or those with unpredictable schedules. The FlexTouch pen delivery system is identical between both treatments, with the same dose escalation principles - you cannot skip doses and must follow the prescribed progression schedule. Whether you choose Wegovy's 0.25mg, 0.5mg, 1mg, 1.7mg, to 2.4mg pathway, or Mounjaro's equivalent progression, consistent weekly injection timing remains crucial for optimal results.
UK Market Position: Compare Mounjaro and Wegovy Availability
The UK weight management market positions these treatments differently when you compare Mounjaro and Wegovy availability and pricing strategies. Wegovy entered the UK market first, establishing competitive pricing structures and becoming widely available through multiple providers, creating price competition that benefits patients. Our £79.99 starting price reflects this market maturity and our commitment to accessible weight management care. Mounjaro's newer market entry typically commands premium pricing, as early-adopter demand often exceeds supply capacity among UK providers.
NICE guidance TA875 specifically recommends Wegovy with specialist weight management support, providing NHS pathway clarity that private providers like EverydayMeds can complement with faster access and flexible pricing options. When comparing Mounjaro and Wegovy through the lens of UK healthcare integration, Wegovy's established position offers greater prescriber familiarity and patient support resources. Both treatments require the same MHRA regulatory compliance and are subject to additional monitoring (Black Triangle ▼), ensuring equivalent safety oversight regardless of your choice.
Making Your Decision: Compare Mounjaro and Wegovy with EverydayMeds
Your choice between Mounjaro and Wegovy ultimately depends on individual factors including budget, tolerance preferences, and clinical suitability - both treatments are available through EverydayMeds with full prescriber support to help you decide. Our transparent pricing means you can compare Mounjaro and Wegovy costs accurately without worrying about hidden fees or subscription traps that some providers use. New customers benefit from code FIRST40, whilst returning customers use DOSE25, ensuring competitive access to either treatment option. Remember that both are prescription-only medicines requiring ongoing clinical assessment and work best alongside a reduced-calorie diet and increased physical activity. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy to explore both options with our experienced clinical team who can guide your decision based on your individual circumstances and treatment goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
